ClinicalTrials.Veeva

Menu

Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases (DVD)

A

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Status

Unknown

Conditions

Neuromuscular Diseases
Acute Exacerbation of COPD
Acute Exacerbation of Asthma
Acute Respiratory Failure
Acute Exacerbation of Bronchiectasis
Obesity Hypoventilation Syndrome
Interstitial Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT04098094
2018-A03192-53

Details and patient eligibility

About

Observational study in patients with chronic respiratory diseases (chronic obstructive pulmonary diseases, bronchiectasis, interstitial lung diseases, neuromuscular diseases, obesity-hypoventilation syndrome...) admitted in intensive care unit for acute respiratory failure. The main objective is to determine the prevalence of right ventricular (RV) dysfunction in this population and to analyze the impact of such a complication on outcomes (survival at day-28, duration of non-invasive or mechanical ventilation, duration of hospital stay). RV function will be assessed by echocardiography at admission, after 3 days and at discharge. Plasma NT-proBNP and troponin levels will be collected.

Full description

Observational study in patients with chronic respiratory diseases (chronic obstructive pulmonary diseases, bronchiectasis, interstitial lung diseases, neuromuscular diseases, obesity-hypoventilation syndrome...) admitted in intensive care unit for acute respiratory failure.

Inclusion Criteria:

  • Chronic respiratory disease (COPD, ILD, OHS...)
  • Admission in ICU for acute respiratory failure
  • Patient's non-opposition

Exclusion Criteria:

  • Patients < 18 year-old
  • Protected patients
  • Pregnant women The main objective is to determine the prevalence of right ventricular (RV) dysfunction in this population and to analyze the impact of such a complication on outcomes (survival at day-28, duration of non-invasive or mechanical ventilation, duration of hospital stay). RV function will be assessed by echocardiography at admission, after 3 days and at discharge. Plasma NT-proBNP and troponin levels will be collected.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic respiratory disease (COPD, ILD, OHS...)
  • Admission in ICU for acute respiratory failure
  • Patient's non-opposition

Exclusion criteria

  • Patients < 18 year-old
  • Protected patients
  • Pregnant women

Trial contacts and locations

1

Loading...

Central trial contact

Athénaïs Boucly, MD; Athénaïs Boucly, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems